Article Contents ::
- 1 Details About Generic Salt :: Amikacin
- 2 Main Medicine Class:: Antibiotic,aminoglycoside
- 3 (am-ih-KAE-sin SULL-fate) Amikin Class: Antibiotic/aminoglycoside
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Amikacin
Main Medicine Class:: Antibiotic,aminoglycoside
(am-ih-KAE-sin SULL-fate)
Amikin
Class: Antibiotic/aminoglycoside
Drugs Class ::
Action Inhibits production of bacterial protein, causing bacterial cell death.
Indications for Drugs ::
Indications Treatment of infections caused by susceptible strains of microorganisms, especially gram-negative bacteria.
Drug Dose ::
Route/Dosage
ADULTS, CHILDREN & INFANTS: IV/IM 15 mg/kg (ideal body weight)/day in 2 or 3 divided doses. Treatment in heavier patients should not exceed 1.5 g/day. UNCOMPLICATED UTIS: IV/IM 250 mg bid. NEONATES: IV/IM Loading dose of 10 mg/kg is recommended followed by 7.5 mg/kg q 12 hr. Lower doses may be needed in first 2 wk of life.
Contraindication ::
Contraindications Generally not indicated for long-term therapy because of ototoxicity and nephrotoxicity.
Drug Precautions ::
Precautions
Pregnancy: Category D. Lactation: Undetermined. Children: Cautious use is necessary in premature infants and neonates because of renal immaturity. Nephrotoxicity/ototoxicity: If patient has signs and symptoms of nephrotoxicity or ototoxicity, discontinuation or dosage adjustment is needed. Renal impairment: Dosage adjustment is needed in patients with this condition.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
EENT: Hearing loss; deafness; loss of balance. GU: Oliguria; proteinuria; increased serum creatinine; urinary casts; red and white blood cells in urine; azotemia. OTHER: Decreased serum magnesium.
Drug Mode of Action ::
Action Inhibits production of bacterial protein, causing bacterial cell death.
Drug Interactions ::
Interactions
Drugs with nephrotoxic potential (eg, cephalosporins, enflurane, methoxyflurane, vancomycin): May increase risk of nephrotoxicity. Loop diuretics (eg, furosemide): May increase risk of auditory toxicity. Neuromuscular blocking agents (eg, tubocurarine): Amikacin may enhance effects of these agents. INCOMPATIBILITIES: Do not mix with betalactam antibiotics (eg, carbenicillin, ticarcillin).
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies. Note hypersensitivity to aminoglycosides.
- Assess renal and auditory function before administration and monitor periodically during therapy to detect nephrotoxicity or ototoxicity.
- Send blood for culture and sensitivity before beginning therapy.
- Monitor patient for signs and symptoms of yeast infections during therapy.
- Monitor I&O during therapy; maintain good hydration.
- Assess patient for signs of infection to determine effectiveness of therapy.
- Notify physician and stop infusion if patient has signs of oliguria or shows signs of renal failure (eg, edema, shortness of breath, pruritus), ototoxicity or anaphylactic reaction.
Drug Storage/Management ::
Administration/Storage
- Dilute with normal saline or D5W according to instructions.
- Administer by IV or IM route only.
- Use volumetric IV pump to regulate delivery.
- Avoid overrapid administration, which may result in respiratory depression and arrest; give over 30 to 60 min.
- Do not mix with or administer within 1 hr of other IV medications because of potential for incompatibility or inactivation.
- Discard diluted solution after 24 hr.
- When giving by IM route, use deep, slow injection; rotate sites to prevent tissue irritation or breakdown.
Drug Notes ::
Patient/Family Education
- Encourage patient to increase fluid intake to 2000 to 3000 ml/day, unless contraindicated.
- Warn patient that diarrhea and abdominal bloating are common side effects of antibiotics.
- Inform patient that improvement should be seen in 3 to 5 days.
- Instruct patient to report the following signs to physician: Hypersensitivity, tinnitus, vertigo, hearing loss.
- Teach patient to look for signs of renal failure and to notify physician immediately if these signs occur.